期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

乳腺癌患者化疗前后血浆TSP-1 VEGF水平变化及意义 被引量：2

原文传递
导出
摘要 目的检测乳腺癌患者血浆TSP-1及VEGF在化疗前后的变化,探讨其临床意义。方法应用酶联免疫吸附法(ELISA)对40例乳腺癌患者化疗前后血浆TSP-1及VEGF测定并对照分析。结果乳腺癌患者化疗前血浆TSP-1为95.56±40.66)ng/ml,VEGF为566.2±46.8ng/ml;化疗2个周期后TSP-1为167.14±56.78)ng/ml,VEGF为465.2±200.6ng/ml,P<0.01。结论乳腺癌患者化疗前后血浆TSP-1及VEGF水平的变化与化疗效果密切相关,TSP-1及VEGF可作为判断化疗疗效的指标之一。
作者 蒿慧玲 黄红霞 陈勇
机构地区 河南省中牟县中医院 郑州市第三人民医院
出处 《医药论坛杂志》 2009年第12期65-66,共2页 Journal of Medical Forum
关键词 乳腺癌 化疗 血浆 VEGF TSP-1
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献4

二级参考文献29

  • 1Miyanaga K, Kato Y, Nakamura T, et al. Expression and Role of Thrombospondin-1 in Colorectal Cancer [J]. Anticancer Res,2002,22:3941 - 3948.
  • 2Albo D, Shinohara T, Tuszynski A. Up-regulation of matrix metalloproteinase 9 by thrombospondin 1 in gastric cancer[J]. J Surg Res,2002,108(1): 51 - 60.
  • 3Qjan X,Pothamen VL, Nicosia RF, et al. Expression of TSP-1 in human pancreatic adenocareinoma: role in matrix metalloproteinase - 9 production [ J ]. Pathol Oncol Res,2001,7(4) :251 - 259.
  • 4Xu M,Kuar D,Stass SA, et al. Gene therapy with P53 and a fragment of TSP-1 inhibits human breast cancer in vivo[J]. Mol Genet Metab, 1998,63(2) :103 - 109.
  • 5Paul B. Thrombospondins as matricellular modulator of cell function[J]. J Clin Invest, 2001,107 (8) : 929 -934.
  • 6Gutierrez LS, Suckow M, Lawler J, et al. Thrombospondin 1-a regulator of adenoma growth and carcinoma progression in the APC (Min/+ ) mouse model[J ].Carcinogenesis, 2003,24 (2) : 199 - 207.
  • 7Tomii Y,Karnochi J,Yamazaki H, et al. Human throm-bospondin 2 inhibits proliferation of microvascular endothelial cells[J]. Int J Oncol, 2002,20(2):339- 342.
  • 8Reiher FK, Volpert OV, Jimenez B, et al. Inhibition of tumor growth by systemic treatment with Thrombospondin-1 peptide mimetics [J]. Int J Cancer, 2002, 98 : 682 - 689.
  • 9Hawighorst T, Oura H, Streit M, et al. Thrombospondin-1 selectively inhibits early-stage carcinogenesis and angiogenesis but not tumor lymphangiogenesis and lymphatic metastasis in transgenic miee[J]. Oncogene, 2002, (21) : 7945 -7956.
  • 10Tan K, Duquette M, Liu JH, et al. Crystal structure of the TSP-1 type 1 repeats:a novel layered fold and its biological implication[ J ]. J Cell Bio, 2002,159 (2) : 373 - 382.

共引文献61

同被引文献23

  • 1丁兆军,张可.乳腺癌新辅助化疗10年预后的影响因素分析[J].现代肿瘤医学,2008,16(11):1935-1937. 被引量：8
  • 2卢锋,乔玲,万菊萍.胃肠道肿瘤患者外周血中SS,TNF-α,IL-6和sIL-2R检测的临床意义[J].第四军医大学学报,2005,26(19):1795-1796. 被引量：12
  • 3庄晓明,谢敏,毕永春.乳腺癌患者外周血浆sIL-2R、IL-6水平测定及其与临床病理的关系[J].实用诊断与治疗杂志,2007,21(9):662-663. 被引量：8
  • 4Iorio M,Casalini P,Piovan C,et al. microRNA-205 regulates HER3 inhuman breast cancer[ J]. CaneerRes ,2009 ,69 (6) :2195-2200.
  • 5Huang EH,Tucker SL,Strom EA,et al. Predictors of loco regional re-currence in patients with locally advanced breast cancer treated withneoadjuvant chemotherapy, mastectomy, and radiotherapy [ J ]. Int JRadiat Oncol Biol Phys,2005 ,62(2) :351- 357.
  • 6Tsujiura M,Ichikawa D,Komatsu S,et al. Circulating microRNAs inplasma of patients with gastric cancers [ J ]. Br J Cancer, 2010 ,102(7):1174-1179.
  • 7Matsuo K,Oka M, Murase K,et al. Express ion of interleukin 6 andits receptor in human gastric and colorectal cancers [ J]. J Int MedRes,2003,31(2) :69-75.
  • 8Riaz M, Berns EM, Sieuwerts AM, et al. Correlation of breast cancer susceptibility loci with patient characteristics, metastasis {ree survival, and mRNA expression of the nearest genes[J]. Breast Cancer Res Treat,2012,13(3) :843-851.
  • 9Alford SH, Toy K, Merajver SD, et al. Increased risk for distant metastasis in patients with familial early stage breast cancer and high EZH2 expression[J]. Breast Cancer Res Treat, 2012,13(2) :429 437.
  • 10Turanli, S. Importance of the development time of isolated bone metastasis in breast cancer[J]. Langenbecks Arch Surg, 2012,39 (7) :967-972.

引证文献2

二级引证文献15

医药论坛杂志
2009年 第12期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部